Why is Metropolis Healt falling/rising?

As of 23-Jul, Metropolis Healthcare Ltd is experiencing a price increase, currently at 2,004.00, reflecting a change of 20.0 (1.01%) upward. The stock has shown a positive performance today, gaining for the last two days with a total return of 3.53%. However, it has underperformed its sector by 0.37%. Over the past week, the stock has risen by 1.12%, and in the last month, it has significantly outperformed the benchmark with a return of 17.72% compared to the Sensex's 1.01%. Despite these gains, there are concerns regarding falling investor participation, as the delivery volume has decreased by 41.56% against the 5-day average. The company boasts high management efficiency with a ROCE of 26.87% and low debt levels, alongside strong institutional holdings at 45.58%, which may support its recent price movement.
In the broader market context, while Metropolis Healthcare has shown a strong short-term performance, it has underperformed in the year-to-date comparison, with a decline of 2.88% against the Sensex's gain of 5.87%. This suggests that despite recent gains, the stock's long-term growth prospects are being questioned due to poor net sales growth and disappointing quarterly results, including a significant drop in profit before tax and profit after tax. The stock's valuation appears expensive with a Price to Book Value of 7.8, and while it has generated a negative return of 1.52% over the past year, its profits have increased by 13.4%, indicating a high PEG ratio of 5.9, which may deter some investors.